{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:20:33Z","timestamp":1760865633677},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T00:00:00Z","timestamp":1287446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00535-010-0333-2","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T08:30:34Z","timestamp":1287390634000},"page":"42-47","source":"Crossref","is-referenced-by-count":20,"title":["Genetic background of autoimmune hepatitis in Japan"],"prefix":"10.1007","volume":"46","author":[{"given":"Kaname","family":"Yoshizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,19]]},"reference":[{"key":"333_CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199604043341406","volume":"334","author":"EL Krawitt","year":"1996","unstructured":"Krawitt EL. Autoimmune hepatitis. N Engl J Med. 1996;334:897\u2013903.","journal-title":"N Engl J Med"},{"key":"333_CR2","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/gast.2001.24227","volume":"120","author":"MP Manns","year":"2001","unstructured":"Manns MP, Strassburg CP. Autoimmune hepatitis: clinical challenges. Gastroenterology. 2001;120:1502\u201317.","journal-title":"Gastroenterology"},{"key":"333_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","volume":"36","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479\u201397.","journal-title":"Hepatology."},{"key":"333_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","volume":"34","author":"MS Longhi","year":"2010","unstructured":"Longhi MS, Ma Y, Mieli-Vergani G, Vergani D. Aetiopathogenesis of autoimmune hepatitis. J Autoimmun. 2010;34:7\u201314.","journal-title":"J Autoimmun"},{"key":"333_CR5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0016-5085(80)90080-3","volume":"79","author":"IR Mackay","year":"1980","unstructured":"Mackay IR, Tait BD. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology. 1980;79:95\u20138.","journal-title":"Gastroenterology"},{"key":"333_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","volume":"13","author":"PT Donaldson","year":"1991","unstructured":"Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 1991;13:701\u20136.","journal-title":"Hepatology"},{"key":"333_CR7","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.1840120609","volume":"12","author":"T Seki","year":"1990","unstructured":"Seki T, Kiyosawa K, Inoko H, Ota M. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. Hepatology. 1990;12:1300\u20134.","journal-title":"Hepatology."},{"key":"333_CR8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","volume":"26","author":"G Toda","year":"1997","unstructured":"Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al. Present status of autoimmune hepatitis in Japan\u2014correlating the characteristics with international criteria in an area with a high rate of HCV infection Japanese National Study Group of Autoimmune Hepatitis. J Hepatol. 1997;26:1207\u201312.","journal-title":"J Hepatol"},{"key":"333_CR9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/332845a0","volume":"332","author":"JH Brown","year":"1988","unstructured":"Brown JH, Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature. 1988;332:845\u201350.","journal-title":"Nature"},{"key":"333_CR10","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","volume":"112","author":"MD Strettell","year":"1997","unstructured":"Strettell MD, Donaldson PT, Thomson LJ, Santrach PJ, Moore SB, Czaja AJ, Williams R. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology. 1997;112:2028\u201335.","journal-title":"Gastroenterology"},{"key":"333_CR11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","volume":"103","author":"T Seki","year":"1992","unstructured":"Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology. 1992;103:1041\u20137.","journal-title":"Gastroenterology."},{"key":"333_CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2007.08.019","volume":"48","author":"YS Lim","year":"2008","unstructured":"Lim YS, Oh HB, Choi SE, Kwon OJ, Heo YS, Lee HC, Suh DJ. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at position 70\u201374 of the HLA-DRB1 molecule. J Hepatol. 2008;48:133\u20139.","journal-title":"J Hepatol"},{"key":"333_CR13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","volume":"30","author":"M Pando","year":"1999","unstructured":"Pando M, Larribia J, Fernandez GC, Fainboim H, Ciocca M, Ramonet M, et al. Pediatric and adult forms of type 1 autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology. 1999;30:1374\u201380.","journal-title":"Hepatology"},{"key":"333_CR14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0168-8278(98)80347-4","volume":"28","author":"MN Vazquez-Garcia","year":"1998","unstructured":"Vazquez-Garcia MN, Alaez C, Olivo A, Debaz H, Perez-Luque E, Burguete A, et al. MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis. J Hepatol. 1998;28:985\u201390.","journal-title":"J Hepatol"},{"key":"333_CR15","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","volume":"94","author":"PL Bittencourt","year":"1999","unstructured":"Bittencourt PL, Goldberg AC, Cancado ELR, Porta G, Carrilho FJ, Farias AQ, et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis type 1 and 2. Am J Gastroenterol. 1999;94:1906\u201313.","journal-title":"Am J Gastroenterol"},{"key":"333_CR16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.12.019","volume":"42","author":"K Yoshizawa","year":"2005","unstructured":"Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K. Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis. J Hepatol. 2005;42:578\u201384.","journal-title":"J Hepatol"},{"key":"333_CR17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840190311","volume":"19","author":"DG Doherty","year":"1994","unstructured":"Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis. Hepatology. 1994;19:609\u201315.","journal-title":"Hepatology"},{"key":"333_CR18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","volume":"174","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev. 2000;174:250\u20139.","journal-title":"Immunol Rev"},{"key":"333_CR19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1872-034X.2007.00204.x","volume":"38","author":"Y Miyake","year":"2008","unstructured":"Miyake Y, Iwasaki Y, Takaki A, Onishi T, Okamoto R, Takaguchi K, et al. Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis. Hepatol Res. 2008;38:96\u2013102.","journal-title":"Hepatol Res"},{"key":"333_CR20","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s10620-009-0995-x","volume":"55","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y, Ikeda K, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H, et al. Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis. Dig Dis Sci. 2010;55:2070\u20136.","journal-title":"Dig Dis Sci"},{"key":"333_CR21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2008.11.005","volume":"8","author":"C Duarte-Rey","year":"2009","unstructured":"Duarte-Rey C, Pardo AL, Rodriguez-Velosa Y, Mantilla RD, Anaya JM, Rojas-Villarraga A. HLA class II association with autoimmune hepatitis in Latin America: a meta-analysis. Autoimmun Rev. 2009;8:325\u201331.","journal-title":"Autoimmun Rev"},{"key":"333_CR22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","volume":"37","author":"AJ Czaja","year":"2002","unstructured":"Czaja AJ, Souto EO, Bittencourt PL, Cancado ELR, Porta G, Goldberg AC, et al. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol. 2002;37:302\u20138.","journal-title":"J Hepatol"},{"key":"333_CR23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/44853","volume":"401","author":"The MHC Sequencing Consortium","year":"1999","unstructured":"The MHC Sequencing Consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature. 1999;401:921\u20133.","journal-title":"Nature"},{"key":"333_CR24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","volume":"30","author":"S Cookson","year":"1999","unstructured":"Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, et al. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis. Hepatology. 1999;30:851\u20136.","journal-title":"Hepatology"},{"key":"333_CR25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","volume":"117","author":"AJ Czaja","year":"1999","unstructured":"Czaja AJ, Cookson S, Constantini PK, Clare M, Underhill JA, Donaldson PT. Cytokine polymorphism associated with clinical features and treatment outcome in type 1 autoimmune hepatitis. Gastroenterology. 1999;117:645\u201352.","journal-title":"Gastroenterology"},{"key":"333_CR26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(01)00072-1","volume":"35","author":"PL Bittencourt","year":"2001","unstructured":"Bittencourt PL, Pal\u00e1cios SA, Can\u00e7ado ELR, Porta G, Drigo S, Carrilho FJ, et al. Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor \u03b1 polymorphisms at position \u2212308. J Hepatol. 2001;35:24\u20138.","journal-title":"J Hepatol"},{"key":"333_CR27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","volume":"31","author":"K Agarwal","year":"2000","unstructured":"Agarwal K, Czaja AJ, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology. 2000;31:49\u201353.","journal-title":"Hepatology"},{"key":"333_CR28","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1872-034X.2008.00337.x","volume":"38","author":"T Umemura","year":"2008","unstructured":"Umemura T, Ota M, Yoshizawa K, Katsuyama Y, Ichijo T, Tanaka E, Kiyosawa K. Association of cytotoxic T lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese. Hepatol Res. 2008;38:689\u201395.","journal-title":"Hepatol Res."},{"key":"333_CR29","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1572-0241.2003.07525.x","volume":"98","author":"PL Bittencourt","year":"2003","unstructured":"Bittencourt PL, Palacios SA, Cancado EL, Porta G, Carrilho FJ, Laudanna AA, et al. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol. 2003;98:1616\u201320.","journal-title":"Am J Gastroenterol"},{"key":"333_CR30","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1572-0241.2005.41053.x","volume":"100","author":"A Hiraide","year":"2005","unstructured":"Hiraide A, Imazeki F, Yokosuka O, Kanda T, Kojima H, Fukai K, et al. Fas polymorphisms influence susceptibility to autoimmune hepatitis. Am J Gastroenterol. 2005;100:1322\u20139.","journal-title":"Am J Gastroenterol"},{"key":"333_CR31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1399-0039.2006.00794.x","volume":"69","author":"K Agarwal","year":"2007","unstructured":"Agarwal K, Czaja AJ, Donaldson PT. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens. 2007;69:227\u201335.","journal-title":"Tissue Antigens"},{"key":"333_CR32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","volume":"35","author":"A Vogel","year":"2002","unstructured":"Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology. 2002;35:126\u201331.","journal-title":"Hepatology"},{"key":"333_CR33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","volume":"20","author":"L Fan","year":"2005","unstructured":"Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol. 2005;20:249\u201355.","journal-title":"J Gastroenterol Hepatol."},{"key":"333_CR34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.clim.2009.11.004","volume":"134","author":"N Paladino","year":"2010","unstructured":"Paladino N, Flores AC, Fainboim H, Schroder T, Cuarterolo M, Lezama C, et al. The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF-beta1. Clin Immunol. 2010;134:305\u201312.","journal-title":"Clin Immunol."},{"key":"333_CR35","first-page":"1780","volume":"51","author":"K Sakaguchi","year":"2004","unstructured":"Sakaguchi K, Kitano M, Nishimura M, Senoh T, Ohta T, Terao M, et al. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Hepatogastroenterology. 2004;51:1780\u20133.","journal-title":"Hepatogastroenterology"},{"key":"333_CR36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330\u20136.","journal-title":"Nat Immunol."},{"key":"333_CR37","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","volume":"176","author":"MS Longhi","year":"2006","unstructured":"Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, Ma Y. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol. 2006;176:4484\u201391.","journal-title":"J Immunol"},{"key":"333_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2005.03.009","volume":"25","author":"M Honda","year":"2005","unstructured":"Honda M, Kawai H, Shirota Y, Yamashita T, Takamura T, Kaneko S. cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation. J Autoimmun. 2005;25:133\u201340.","journal-title":"J Autoimmun"},{"key":"333_CR39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.21518","volume":"45","author":"S Yokosawa","year":"2007","unstructured":"Yokosawa S, Yoshizawa K, Ota M, Katsuyama Y, Kawa S, Ichijo T, et al. A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1. Hepatology. 2007;45:384\u201390.","journal-title":"Hepatology."}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-010-0333-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0333-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T01:10:08Z","timestamp":1636679408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-010-0333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,19]]},"references-count":39,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1007\/s00535-010-0333-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,19]]}}}